{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:04:20Z","timestamp":1781899460735,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005341","name":"Bayerisches Staatsministerium f\u00fcr Wissenschaft, Forschung und Kunst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4t Augsburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Post-COVID-Fatigue (PCF) is one of the most reported symptoms following SARS-CoV-2 infection. Currently, research on persistent symptoms focuses mainly on severe infections, while outpatients are rarely included in observations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate whether the severity of PCF is related to the number of acute and persistent symptoms due to mild-to-moderate COVID-19 and to compare the most common symptoms during acute infection with the persistent symptoms in PCF patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 425 participants were examined after COVID-19 treated as an outpatient (median 249\u00a0days [IQR: 135; 322] after acute disease) at the site of University Hospital Augsburg, Germany. The Fatigue Assessment Scale (FAS) was used to quantify the severity of PCF. The number of symptoms (maximum 41) during acute infection and persistent symptoms (during the last 14\u00a0days before examination) were added up to sum scores. Multivariable linear regression models were used to show the association between the number of symptoms and PCF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 425 participants, 37% (<jats:italic>n<\/jats:italic>\u2009=\u2009157) developed PCF; most were women (70%). The median number of symptoms was significantly higher in the PCF group than in the non-PCF group at both time points. In multivariable linear regression models, both sum scores were associated with PCF (acute symptoms: \u03b2-estimate per additional symptom [95%-CI]: 0.48 [0.39; 0.57], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001); persistent symptoms: \u03b2-estimate per additional symptom [95%-CI]: 1.18 [1.02; 1.34], <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). The acute symptoms strongest associated with PCF severity were difficulty concentrating, memory problems, dyspnea or shortness of breath on exertion, palpitations, and problems with movement coordination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Each additional symptom that occurs in COVID-19 increases the likelihood of suffering a higher severity of PCF. Further research is needed to identify the aetiology of PCF.<\/jats:p>\n                <jats:p>Trial registration: Nr. NCT04615026. Date of registration: November 4, 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-023-11752-9","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:11:38Z","timestamp":1684854698000},"page":"3294-3302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting"],"prefix":"10.1007","volume":"270","clinical-trial-number":[{"clinical-trial-number":"nct04615026","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2606-8655","authenticated-orcid":false,"given":"Lena","family":"Schmidbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Kirchberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Go\u00dflau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias D.","family":"Warm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hyhlik-D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Linseisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Meisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"11752_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, de Meirleir KL et al (2011) Myalgic encephalomyelitis: international consensus criteria. J Intern Med 270:327\u2013338. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02428.x","journal-title":"J Intern Med"},{"key":"11752_CR2","unstructured":"Scheibenbogen C, Volk H-D, Grabowski P et al (2014) Chronisches fatigue-Syndrom: Heutige Vorstellung zur pathogenese, diagnostik und therapie. https:\/\/immunologie.charite.de\/fileadmin\/user_upload\/microsites\/m_cc12\/immunologie\/Immundefekt-Ambulanz\/Chronisches_Fatigue-Syndrom.pdf. Accessed 26 Jul 2022"},{"key":"11752_CR3","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen N21-01-ME\/CFS: Aktueller Kenntnisstand\u2014Berichtsplan\u2014Version 1.0 (2022) https:\/\/www.iqwig.de\/download\/n21-01_me-cfs-aktueller-kenntnisstand_berichtsplan_v1-0.pdf. Accessed 26 Jul 2022"},{"key":"11752_CR4","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/healthcare9111586","volume":"9","author":"S Kwon","year":"2021","unstructured":"Kwon S, Jin C, Cho S-Y et al (2021) Analysis of factors affecting post-stroke fatigue: an observational, cross-sectional, retrospective chart review study. Healthcare (Basel) 9:1586. https:\/\/doi.org\/10.3390\/healthcare9111586","journal-title":"Healthcare (Basel)"},{"key":"11752_CR5","unstructured":"Musch S (2020) ME\/CFS k\u00f6nnte die deutsche Volkswirtschaft jedes Jahr 7,4 Milliarden Euro kosten. https:\/\/www.mecfs.de\/me-cfs-koennte-die-deutsche-volkswirtschaft-jedes-jahr-74-milliarden-euro-kosten\/. Accessed 29 May 2022"},{"key":"11752_CR6","doi-asserted-by":"publisher","first-page":"e0240784","DOI":"10.1371\/journal.pone.0240784","volume":"15","author":"L Townsden","year":"2020","unstructured":"Townsden L, Dyer AH, Jones K et al (2020) Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE 15:e0240784. https:\/\/doi.org\/10.1371\/journal.pone.0240784","journal-title":"PLoS ONE"},{"key":"11752_CR7","doi-asserted-by":"publisher","first-page":"628741","DOI":"10.3389\/fimmu.2021.628741","volume":"12","author":"RS K\u00f6nig","year":"2021","unstructured":"K\u00f6nig RS, Albrich WC, Kahlert CR et al (2021) The gut microbiome in myalgic encephalomyelitis (ME)\/chronic fatigue syndrome (CFS). Front Immunol 12:628741. https:\/\/doi.org\/10.3389\/fimmu.2021.628741","journal-title":"Front Immunol"},{"key":"11752_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet 397:220\u2013232. https:\/\/doi.org\/10.1016\/S0140-6736(20)32656-8","journal-title":"The Lancet"},{"key":"11752_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601\u2013615. https:\/\/doi.org\/10.1038\/s41591-021-01283-z","journal-title":"Nat Med"},{"key":"11752_CR10","doi-asserted-by":"publisher","first-page":"902140","DOI":"10.3389\/fimmu.2022.902140","volume":"13","author":"C Meisinger","year":"2022","unstructured":"Meisinger C, Go\u00dflau Y, Warm TD et al (2022) Post-COVID-19 fatigue and SARS-CoV-2 specific humoral and T-cell responses in male and female outpatients. Front Immunol 13:902140. https:\/\/doi.org\/10.3389\/fimmu.2022.902140","journal-title":"Front Immunol"},{"key":"11752_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/ijerph18042030","volume":"18","author":"K Stavem","year":"2021","unstructured":"Stavem K, Ghanima W, Olsen MK et al (2021) Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health 18:256. https:\/\/doi.org\/10.3390\/ijerph18042030","journal-title":"Int J Environ Res Public Health"},{"key":"11752_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-021-02833-2","volume":"19","author":"KJ Wirth","year":"2021","unstructured":"Wirth KJ, Scheibenbogen C (2021) Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). J Transl Med 19:162. https:\/\/doi.org\/10.1186\/s12967-021-02833-2","journal-title":"J Transl Med"},{"key":"11752_CR13","doi-asserted-by":"publisher","first-page":"e071050","DOI":"10.1136\/bmj-2022-071050","volume":"379","author":"RS Peter","year":"2022","unstructured":"Peter RS, Nieters A, Kr\u00e4usslich H-G et al (2022) Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ 379:e071050. https:\/\/doi.org\/10.1136\/bmj-2022-071050","journal-title":"BMJ"},{"key":"11752_CR14","doi-asserted-by":"publisher","unstructured":"Rauch B, Kern-Matschilles S, Haschka SJ et al (2021) COVID-19-related symptoms 6 months after the infection\u2014update on a prospective cohort study in Germany. https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2021.02.12.21251619v1.full-text. Accessed 26 Jul 2022","DOI":"10.1101\/2021.02.12.21251619v1.full-text"},{"key":"11752_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.27.21250617","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.27.21250617","journal-title":"medRxiv"},{"key":"11752_CR16","doi-asserted-by":"publisher","first-page":"101651","DOI":"10.1016\/j.eclinm.2022.101651","volume":"53","author":"TJ Hartung","year":"2022","unstructured":"Hartung TJ, Neumann C, Bahmer T et al (2022) Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. EClinicalMedicine 53:101651. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101651","journal-title":"EClinicalMedicine"},{"key":"11752_CR17","unstructured":"Charti\u00e9\u2014Universit\u00e4tsmedizin Berlin Post-COVID-Fatigue: Infolge von COVID treten eine Reihe von Langzeitfolgen auf, bei denen Fatigue ein h\u00e4ufiges Symptom ist (2022) https:\/\/cfc.charite.de\/fuer_patienten\/post_covid_fatigue\/. Accessed 11 Jul 2022"},{"key":"11752_CR18","unstructured":"World Health Organization (2022) Coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int\/. Accessed 26 Jul 2022"},{"key":"11752_CR19","unstructured":"Blankenfeld H, Kaduszkiewicz H, Kochen MM et al (2022) SARS-CoV-2\/Covid-19-Informationen & Praxishilfen f\u00fcr niedergelassene Haus\u00e4rztinnen und Haus\u00e4rzte: S2e-Leitlinie. https:\/\/www.degam.de\/files\/Inhalte\/Leitlinien-Inhalte\/Dokumente\/DEGAM-S2-Leitlinien\/053-054_S2e_SARS-CoV-2%20und%20COVID-19\/V22\/053-054l_S2e%20Coronavirus_V22_22-02-2022.pdf. Accessed 1 Jul 2022"},{"key":"11752_CR20","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","volume":"45","author":"S Zaim","year":"2020","unstructured":"Zaim S, Chong JH, Sankaranarayanan V et al (2020) COVID-19 and multiorgan response. Curr Probl Cardiol 45:100618. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100618","journal-title":"Curr Probl Cardiol"},{"key":"11752_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12967-021-03143-3","volume":"19","author":"KJ Wirth","year":"2021","unstructured":"Wirth KJ, Scheibenbogen C, Paul F (2021) An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. J Transl Med 19:471. https:\/\/doi.org\/10.1186\/s12967-021-03143-3","journal-title":"J Transl Med"},{"key":"11752_CR22","unstructured":"ild care foundation (2022) How to use the Fatigue Assessment Scale (FAS)? https:\/\/www.ildcare.nl\/index.php\/how-to-use-the-fas-fatigue-assessment-scale\/. Accessed 01 Jul 2022"},{"key":"11752_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0022-3999(02)00392-6","volume":"54","author":"HJ Michielsen","year":"2003","unstructured":"Michielsen HJ, de Vries J, van Heck GL (2003) Psychometric qualities of a brief self-rated fatigue measure. J Psychosom Res 54:345\u2013352. https:\/\/doi.org\/10.1016\/s0022-3999(02)00392-6","journal-title":"J Psychosom Res"},{"key":"11752_CR24","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH-B Lam","year":"2009","unstructured":"Lam MH-B, Wing Y-K, Yu MW-M et al (2009) Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med 169:2142\u20132147. https:\/\/doi.org\/10.1001\/archinternmed.2009.384","journal-title":"Arch Intern Med"},{"key":"11752_CR25","doi-asserted-by":"publisher","first-page":"947973","DOI":"10.3389\/fpsyt.2022.947973","volume":"13","author":"J Joli","year":"2022","unstructured":"Joli J, Buck P, Zipfel S et al (2022) Post-COVID-19 fatigue: a systematic review. Front Psychiatry 13:947973. https:\/\/doi.org\/10.3389\/fpsyt.2022.947973","journal-title":"Front Psychiatry"},{"key":"11752_CR26","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S0140-6736(94)92833-9","volume":"344","author":"H Cope","year":"1994","unstructured":"Cope H, David A, Pelosi A et al (1994) Predictors of chronic \u201cpostviral\u201d fatigue. The Lancet 344:864\u2013868. https:\/\/doi.org\/10.1016\/S0140-6736(94)92833-9","journal-title":"The Lancet"},{"key":"11752_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12992-020-00589-w","volume":"16","author":"N Salari","year":"2020","unstructured":"Salari N, Hosseinian-Far A, Jalali R et al (2020) Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health 16:57. https:\/\/doi.org\/10.1186\/s12992-020-00589-w","journal-title":"Glob Health"},{"key":"11752_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jad.2005.06.009","volume":"89","author":"A Wenzel","year":"2005","unstructured":"Wenzel A, Steer RA, Beck AT (2005) Are there any gender differences in frequency of self-reported somatic symptoms of depression? J Affect Disord 89:177\u2013181. https:\/\/doi.org\/10.1016\/j.jad.2005.06.009","journal-title":"J Affect Disord"},{"key":"11752_CR29","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis HE, Assaf GS, Mc-Corkell L et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101019","journal-title":"EClinicalMedicine"},{"key":"11752_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/fampra\/cmab076","volume":"39","author":"SAM van Kessel","year":"2022","unstructured":"van Kessel SAM, Olde Hartman TC, Lucassen PLBJ et al (2022) Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract 39:159\u2013167. https:\/\/doi.org\/10.1093\/fampra\/cmab076","journal-title":"Fam Pract"},{"key":"11752_CR31","doi-asserted-by":"publisher","first-page":"e2111417","DOI":"10.1001\/jamanetworkopen.2021.11417","volume":"4","author":"T Nasserie","year":"2021","unstructured":"Nasserie T, Hittle M, Goodman SN (2021) Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 4:e2111417. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.11417","journal-title":"JAMA Netw Open"},{"key":"11752_CR32","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.cmi.2021.05.033","volume":"27","author":"M Peghin","year":"2021","unstructured":"Peghin M, Palese A, Venturini M et al (2021) Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 27:1507\u20131513. https:\/\/doi.org\/10.1016\/j.cmi.2021.05.033","journal-title":"Clin Microbiol Infect"},{"key":"11752_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3201\/eid2702.203729","volume":"27","author":"GM Vahey","year":"2021","unstructured":"Vahey GM, Marshall KE, McDonald E et al (2021) Symptom profiles and progression in hospitalized and nonhospitalized patients with coronavirus disease, Colorado, USA, 2020. Emerg Infect Dis 27:385\u2013395. https:\/\/doi.org\/10.3201\/eid2702.203729","journal-title":"Emerg Infect Dis"},{"key":"11752_CR34","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/s41467-022-29521-z","volume":"13","author":"M Whitaker","year":"2022","unstructured":"Whitaker M, Elliott J, Chadeau-Hyam M et al (2022) Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 13:1957. https:\/\/doi.org\/10.1038\/s41467-022-29521-z","journal-title":"Nat Commun"},{"key":"11752_CR35","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/cid\/ciab611","volume":"74","author":"J See\u00dfle","year":"2022","unstructured":"See\u00dfle J, Waterboer T, Hippchen T et al (2022) Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis 74:1191\u20131198. https:\/\/doi.org\/10.1093\/cid\/ciab611","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11752-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11752-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11752-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T16:06:39Z","timestamp":1686758799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11752-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["11752"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11752-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by Ethic committee of the Ludwig-Maximilians-University Munich (No. 20-735). The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}